{
  "question": "Following a myocardial infarct, a 40-year-old man is being treated prophylactically with propranolol. You would be concerned about the use of this drug if the patient also had what comorbid condition",
  "is_multi_choice": true,
  "correct_answer": "opc",
  "options": {
    "opa": "Glaucoma",
    "opb": "Essential tremor",
    "opc": "Diabetes",
    "opd": "Supraventricular tachycardia"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "causal_graph": {
    "nodes": [
      [
        "hypoglycemia",
        "Diabetes"
      ]
    ],
    "relationships": [
      [
        "CAUSES"
      ]
    ],
    "paths": [
      "(hypoglycemia)-CAUSES->(Diabetes)"
    ]
  },
  "knowledge_graph": {
    "nodes": [
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ],
      [
        "Propranolol",
        "Pharmaceutical Preparations",
        "Adrenergic beta-Antagonists"
      ]
    ],
    "relationships": [
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ]
    ],
    "paths": [
      "(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)",
      "(Propranolol)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)"
    ]
  },
  "enhanced_graph": {
    "nodes": [],
    "relationships": [],
    "paths": [
      "(Propranolol)-INTERACTS_WITH/ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Adrenergic beta-Antagonists)-Antagonists)"
    ]
  },
  "reasoning_chain": [
    "CHAIN: \"Propranolol\" -> \"beta-blocker\" -> \"decreased heart rate\" -> \"decreased hypoglycemia awareness\" -> \"Diabetes\" -> 85%",
    "CHAIN: \"Propranolol\" -> \"beta-blocker\" -> \"bronchoconstriction\" -> \"possible asthma exacerbation\" -> \"unclear\" -> 60%",
    "CHAIN: \"Propranolol\" -> \"beta-blocker\" -> \"decreased heart rate\" -> \"decreased cardiac output\" -> \"Supraventricular tachycardia\" -> 70%",
    "CHAIN: \"Propranolol\" -> \"beta-blocker\" -> \"decreased intraocular pressure\" -> \"Glaucoma\" -> 50%",
    "CHAIN: \"Propranolol\" -> \"beta-blocker\" -> \"decreased tremor amplitude\" -> \"Essential tremor\" -> 40%"
  ],
  "enhanced_information": "Propranolol is a non-selective beta-blocker that can have significant effects on various comorbid conditions. In patients with diabetes, propranolol can mask hypoglycemia symptoms, which is a critical concern for diabetic patients. Therefore, the reasoning chain indicating a concern with diabetes is valid. In patients with asthma, propranolol can cause bronchoconstriction, potentially exacerbating asthma symptoms, which is also a significant concern. However, the reasoning chain for glaucoma is misleading; while propranolol can lower intraocular pressure, it is not contraindicated in glaucoma. For essential tremor, propranolol is often used as a treatment, so the concern is minimal. Lastly, in the case of supraventricular tachycardia, propranolol is used to manage this condition, so it is not a concern. Thus, the most significant concern regarding the use of propranolol in this patient would be if he also had diabetes.",
  "analysis": "Propranolol is a non-selective beta-blocker that can have various effects on comorbid conditions. In patients with diabetes, one of the significant concerns is that propranolol can mask the symptoms of hypoglycemia, which can lead to dangerous situations if the patient is unaware of low blood sugar levels. This is a critical consideration in managing patients with diabetes. In contrast, propranolol is often used to treat essential tremor and is indicated for managing supraventricular tachycardia, making these conditions less concerning in the context of propranolol use. While it can lower intraocular pressure, propranolol is not contraindicated in glaucoma. Therefore, the most significant concern regarding the use of propranolol in this patient would be if he also had diabetes, as it poses a risk of masking hypoglycemic symptoms. Thus, the best-supported option is diabetes.",
  "answer": "opc",
  "confidence": 90.0,
  "chain_coverage": {
    "success_counts": [
      2,
      1,
      1,
      1,
      1
    ],
    "coverage_rates": [
      33.33333333333333,
      16.666666666666664,
      16.666666666666664,
      16.666666666666664,
      16.666666666666664
    ],
    "total_successes": 6
  },
  "normal_results": []
}